Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
  1. 4 Grant or award President and CEO acquired 400,145 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy President and CEO bought 55,000 shares at $0.47 ($25,795)
  6. 4 Open-market buy Chief Financial Officer bought 28,700 shares at $0.68 ($19,430)
  7. 4 Open-market buy Head of Strategic Partnerships bought 50,000 shares at an average $0.63 ($31,316)
  8. 4 Open-market buy Director bought 3,000 shares at $0.74 ($2,227)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Conversion Chief Scientific Officer acquired 750 shares (conversion)
  18. 4 Conversion Chief Financial Officer acquired 938 shares (conversion)
  19. 4 Conversion Director acquired 325 shares (conversion)
  20. 4 Other acquisition Director acquired 8 shares (other)

Page 3 of 16 · 307 filings